BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25602796)

  • 21. "Equivocal" high-risk HPV DNA tests performed on ThinPrep specimens after ASC-US diagnoses are associated with an increased incidence of CIN3: a cytologic/histologic review of 315 cases.
    HooKim K; Lieberman RW; Smola BM; Knoepp SM
    J Low Genit Tract Dis; 2014 Oct; 18(4):291-7. PubMed ID: 24859841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management.
    Castle PE; Aslam S; Behrens C
    Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1595-1599. PubMed ID: 27587789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.
    Tian R; Cui Z; He D; Tian X; Gao Q; Ma X; Yang JR; Wu J; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Zhong H; Fan W; Chen Y; Jin Z; Cao C; Yu M; Xie W; Huang Z; Bao Y; Xie H; Yao S; Hu Z
    Carcinogenesis; 2019 Oct; 40(10):1220-1228. PubMed ID: 31102403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 25. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
    Dijkstra MG; Heideman DA; de Roy SC; Rozendaal L; Berkhof J; van Krimpen K; van Groningen K; Snijders PJ; Meijer CJ; van Kemenade FJ
    J Clin Pathol; 2010 Nov; 63(11):972-7. PubMed ID: 20924035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.
    Bruno MT; Scalia G; Cassaro N; Boemi S
    BMC Cancer; 2020 May; 20(1):444. PubMed ID: 32429930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of cervical intraepithelial neoplasia diagnosis on histological review of cervical punch biopsies from a visual inspection with acetic acid and HPV detection-based screening program.
    Mittal S; Ghosh I; Banerjee D; Singh P; Biswas J; Nijhawan R; Srinivasan R; Ray C; Basu P
    Int J Gynaecol Obstet; 2014 Sep; 126(3):227-31. PubMed ID: 24947603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
    Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience.
    Hong DK; Kim SA; Lim KT; Lee KH; Kim TJ; So KA
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():173-176. PubMed ID: 30933887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel.
    Heideman DAM; Xu L; Hesselink AT; Doorn S; Ejegod DM; Pedersen H; Quint WGV; Bonde J; Arbyn M
    J Clin Virol; 2019 Dec; 121():104201. PubMed ID: 31629967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of cervical precancer among HPV-negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study.
    Inturrisi F; Rozendaal L; Veldhuijzen NJ; Heideman DAM; Meijer CJLM; Berkhof J
    PLoS Med; 2022 Oct; 19(10):e1004115. PubMed ID: 36306283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.
    Wentzensen N; Clarke MA; Bremer R; Poitras N; Tokugawa D; Goldhoff PE; Castle PE; Schiffman M; Kingery JD; Grewal KK; Locke A; Kinney W; Lorey TS
    JAMA Intern Med; 2019 Jul; 179(7):881-888. PubMed ID: 31081870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can HPV-16 genotyping provide a benchmark for cervical biopsy specimen interpretation?
    Galgano MT; Castle PE; Stoler MH; Solomon D; Schiffman M
    Am J Clin Pathol; 2008 Jul; 130(1):65-70. PubMed ID: 18550472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of pathologists' utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations.
    Singh C; Manivel JC; Truskinovsky AM; Savik K; Amirouche S; Holler J; Thyagarajan B; Gulbahce HE; Pambuccian SE
    Arch Pathol Lab Med; 2014 Jan; 138(1):76-87. PubMed ID: 24377814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.
    Wentzensen N; Schiffman M; Dunn ST; Zuna RE; Walker J; Allen RA; Zhang R; Sherman ME; Wacholder S; Jeronimo J; Gold MA; Wang SS
    Int J Cancer; 2009 Feb; 124(4):964-9. PubMed ID: 19030188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection].
    Wang HR; Liao GD; Jiang Y; Li YC; Qiao YL; Chen W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1241-1245. PubMed ID: 28910940
    [No Abstract]   [Full Text] [Related]  

  • 40. HPV RNA in situ hybridization can inform cervical cytology-histology correlation.
    Coppock JD; Willis BC; Stoler MH; Mills AM
    Cancer Cytopathol; 2018 Aug; 126(8):533-540. PubMed ID: 29975461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.